Annual SG&A
$7.29 M
-$500.10 K-6.42%
31 December 2023
Summary:
Context Therapeutics annual selling, general & administrative expenses is currently $7.29 million, with the most recent change of -$500.10 thousand (-6.42%) on 31 December 2023. During the last 3 years, it has risen by +$6.36 million (+683.27%). CNTX annual SG&A is now -6.42% below its all-time high of $7.79 million, reached on 31 December 2022.CNTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.88 M
+$172.20 K+10.11%
01 September 2024
Summary:
Context Therapeutics quarterly selling, general & administrative expenses is currently $1.88 million, with the most recent change of +$172.20 thousand (+10.11%) on 01 September 2024. Over the past year, it has increased by +$180.90 thousand (+10.67%). CNTX quarterly SG&A is now -11.99% below its all-time high of $2.13 million, reached on 31 March 2023.CNTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$305.19 M
-$30.15 M-10.96%
01 September 2024
Summary:
Context Therapeutics TTM selling, general & administrative expenses is currently -$305.19 million, with the most recent change of -$30.15 million (-10.96%) on 01 September 2024. Over the past year, it has dropped by -$312.59 million (-4226.37%). CNTX TTM SG&A is now -1523.56% below its all-time high of $7.85 million, reached on 30 September 2022.CNTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.4% | +10.7% | -4226.4% |
| 3 y3 years | +683.3% | +126.5% | -10000.0% |
| 5 y5 years | - | - | - |
CNTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.4% | +683.3% | -12.0% | +126.5% | -241.5% | at low |
| 5 y | 5 years | -6.4% | +683.3% | -12.0% | +974.0% | -1523.6% | at low |
| alltime | all time | -6.4% | +683.3% | -12.0% | +974.0% | -1523.6% | at low |
Context Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.88 M(+10.1%) | $7.06 M(+2.6%) |
| June 2024 | - | $1.70 M(-7.9%) | $6.88 M(-1.8%) |
| Mar 2024 | - | $1.85 M(+13.4%) | $7.01 M(-3.9%) |
| Dec 2023 | $7.29 M(-6.4%) | $1.63 M(-3.8%) | $7.29 M(-1.4%) |
| Sept 2023 | - | $1.70 M(-7.4%) | $7.40 M(-3.6%) |
| June 2023 | - | $1.83 M(-14.1%) | $7.67 M(-2.0%) |
| Mar 2023 | - | $2.13 M(+22.7%) | $7.83 M(+0.5%) |
| Dec 2022 | $7.79 M | $1.74 M(-11.8%) | $7.79 M(-0.8%) |
| Sept 2022 | - | $1.97 M(-1.0%) | $7.85 M(+17.0%) |
| June 2022 | - | $1.99 M(-4.8%) | $6.71 M(+26.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $2.09 M(+16.3%) | $5.32 M(+46.5%) |
| Dec 2021 | $3.63 M(+290.3%) | $1.80 M(+117.1%) | $3.63 M(+80.8%) |
| Sept 2021 | - | $828.50 K(+37.0%) | $2.01 M(+47.4%) |
| June 2021 | - | $604.60 K(+50.5%) | $1.36 M(+30.6%) |
| Mar 2021 | - | $401.60 K(+129.9%) | $1.04 M(+12.2%) |
| Dec 2020 | $930.70 K(-68.6%) | $174.70 K(-4.2%) | $930.70 K(+23.1%) |
| Sept 2020 | - | $182.40 K(-36.1%) | $756.00 K(+31.8%) |
| June 2020 | - | $285.40 K(-1.0%) | $573.60 K(+99.0%) |
| Mar 2020 | - | $288.20 K | $288.20 K |
| Dec 2019 | $2.97 M | - | - |
FAQ
- What is Context Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Context Therapeutics?
- What is Context Therapeutics annual SG&A year-on-year change?
- What is Context Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Context Therapeutics?
- What is Context Therapeutics quarterly SG&A year-on-year change?
- What is Context Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Context Therapeutics?
- What is Context Therapeutics TTM SG&A year-on-year change?
What is Context Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of CNTX is $7.29 M
What is the all time high annual SG&A for Context Therapeutics?
Context Therapeutics all-time high annual selling, general & administrative expenses is $7.79 M
What is Context Therapeutics annual SG&A year-on-year change?
Over the past year, CNTX annual selling, general & administrative expenses has changed by -$500.10 K (-6.42%)
What is Context Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of CNTX is $1.88 M
What is the all time high quarterly SG&A for Context Therapeutics?
Context Therapeutics all-time high quarterly selling, general & administrative expenses is $2.13 M
What is Context Therapeutics quarterly SG&A year-on-year change?
Over the past year, CNTX quarterly selling, general & administrative expenses has changed by +$180.90 K (+10.67%)
What is Context Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of CNTX is -$305.19 M
What is the all time high TTM SG&A for Context Therapeutics?
Context Therapeutics all-time high TTM selling, general & administrative expenses is $7.85 M
What is Context Therapeutics TTM SG&A year-on-year change?
Over the past year, CNTX TTM selling, general & administrative expenses has changed by -$312.59 M (-4226.37%)